Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1025-1030

  Park, In H ^a   Kim, Mi K ^b   Kim, Seung U ^a,c  

^a Gachon University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Cisplatin; Hybrid neuron; p21; p53; Ursodeoxycholic acid (UDCA)

Indexed keywords

CISPLATIN; PROTEIN P53; URSODEOXYCHOLIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA FRAGMENTATION; IMMUNOBLOTTING; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPROTECTION; MICE; NEUROPROTECTIVE AGENTS; SENSORY RECEPTOR CELLS; TUMOR SUPPRESSOR PROTEIN P53; URSODEOXYCHOLIC ACID;

EID: 56349117478     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.014     Document Type: Article

References (31)

1. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., and Standefer J.C. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic and toxicologic studies. Cancer 54 (1984) 1269-1275
2. Gregg R.S., Molepo J.M., Monpetit V.J.A., Mikael N.Z., Redmond D., Gadia M., and Stewart D.J. Cisplatin neurotoxicity: The relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J. Clin. Oncol. 10 (1992) 795-803
3. Krarup-Hansen A., Fugleholm K., Helweg-Larsen S., Hauge E.N., Schmalbruch H., Trojaborg W., and Krarup C. Examination of distal involvement in cisplatin-induced neuropathy in man. Brain 116 (1993) 1017-1041
4. Boekelheide K., Arcila M.E., and Eveleth J. Cis-diamminedi-chloroplatinum (II) (cisplatin) alters microtubule assembly dynamics. Toxicol. Appl. Pharmacol. 116 (1992) 146-151
5. Russell J.W., Windebank A.J., McNiven M.A., Brat D.J., and Brimijoin W.S. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin-induced neurotoxicity. Brain Res. 676 (1995) 258-267
6. Gill J.S., and Windebank A.J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Invest. 101 (1998) 2842-2850
7. Liu W., Staecker H., Stupak H., Malgrange B., Lefebvre P., and van de Water T.R. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport. 9 (1998) 2609-2614
8. Masuda H., Tanaka T., and Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem. Biophys. Res. Commun. 203 (1994) 1175-1180
9. Hamers F.P., Brakkee J.H., Cavalletti E., Tedeschi M., Marmonti L., Pezzoni G., Neijt J.P., and Gispen W.H. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res. 53 (1993) 544-549
10. Smyth J.F., Bowman A., Perren T., Wilkinson P., Prescott R.J., Quinn K.J., and Tedeschi M. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of double-blind, randomised trial. Ann. Oncol. 8 (1997) 569-573
11. Park S.A., Choi K.S., Bang J.H., Huh K., and Kim S.U. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J. Neurochem. 75 (2000) 946-953
12. Beuers U., Boyer J.L., and Paumgartner G. Ursodeoxycholic acid in cholestasis: Effects on intracellular potential mechanisms of action and therapeutic applications. Hepatol. 28 (1998) 1449-1453
13. Rodrigues C.M., Fan G., Ma X., Kren B.T., and Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101 (1998) 2790-2799
14. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., and Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6 (1999) 842-854
15. Rodrigues C.M., Stieers C.L., Keene C.D., Ma X., Kren B.T., Low W.C., and Steer C.J. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: Evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem. 75 (2000) 2368-2379
16. Keene C.D., Rodrigues C.M., Eich T., Linehan-Stieers C., Abt A., Kren B.T., Steer C.J., and Low W.C. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Exp. Neurol. 171 (2001) 351-360
17. Keene C.D., Rodrigues C.M., Eich T., Chhabra M.S., Steer C.J., and Low W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Nat. Acad. Sci. USA 99 (2002) 10671-10676
18. Rodrigues C.M., Spellman S.R., Sola S., Grande A.W., Linehan-Stieers C., Low W.C., and Steer C.J. Neuroprotection by a bile acid in an acute stroke model in the rat. J. Cereb. Blood Flow Met. 22 (2002) 463-471
19. Rodrigues C.M., Sola S., Nan Z., Castro R.E., Ribeiro P.S., Low W.C., and Steer C.J. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Nat. Acad. Sci. USA 100 (2003) 6087-6092
20. Lapenna D., Ciofani G., Festi D., Neri M., Pierdomenico S.D., Giamberardino M.A., and Cuccurullo F. Antioxidant properties of ursodeoxycholic acid. Biochem. Pharmacol. 64 (2002) 1661-1667
21. Sanfeliu C., Wright J.M., and Kim S.U. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line. Neurotoxicology 20 (1999) 935-944
22. 2+ in dorsal root ganglion hybrid neurons. Brit. J. Pharmacol. 104 (2001) 1175-1184
23. Gervais J.L., Seth P., and Zhang H. Cleavage of CDK inhibitor p21 (Cip1/Wafl) by caspase is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273 (1998) 19207-19212
24. Zhang Y., Fujita N., and Tsuruo T. Caspase-mediated cleavage of p21 Wafl/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 18 (1999) 1131-1138
25. Fulda S., Sieverts H., Friesen C., Herr I., and Debatin K. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57 (1997) 3823-3829
26. Muller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., Friedman S.L., Galle P.R., Stremmel W., Oren M., and Krammer P.H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188 (1998) 2033-2045
27. Hong M., Lai M.D., Lin Y.S., and Lai M.Z. Antagonism of p53-dependent apoptosis by mitogen signals. Cancer Res. 59 (1999) 2847-2852
28. Heathcote E.J. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31 (2000) 1005-1013
29. Choi Y.H., Im E.O., Suh H., Jin Y., Lee W.H., Yoo Y.H., Kim K.W., and Kim N.D. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int. J. Oncol. 18 (2001) 979-984
30. Sola S., Amaral J.D., Aranha M.M., Steer C.J., and Rodrigues C.M. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. Curr. Med. Chem. 13 (2006) 3039-3051
31. Mitsuyoshi H., Nakashima T., Sumida Y., Yoh T., Nakajima Y., Ishikawa H., Inaba K., Sakamoto Y., Okanoue T., and Kashima K. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem. Biophys. Res. Comm. 263 (1999) 537-542